Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion type Assertion NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_head.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion evidence source_evidence_literature NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion SIO_000772 25468223 NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion wasDerivedFrom befree-20150227 NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion wasGeneratedBy ECO_0000203 NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.